Meropenem IV infusion bulk supplier for pharma manufacturers

Meropenem Iv Infusion 500 mg, 1 g, 2 g in vials Suppliers & Bulk Manufacturers

Available Forms: Powder for Reconstitution

Available Strengths: 500 mg, 1 g, 2 g in vials

Reference Brands: Merrem (US & EU), Merosan (india)

Meropenem IV inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to bacterial lysis. It offers broad-spectrum activity against resistant gram-negative and gram-positive bacteria, including Pseudomonas. Benefits include rapid, potent bactericidal effect, excellent tissue penetration, and use in critical infections, ensuring reliable, effective treatment in hospital settings.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Meropenem IV infusion is approved in the EU and US for severe bacterial infections including pneumonia, urinary tract infections, and intra-abdominal sepsis. In the EU, brands like Merrem are regulated by EMA with dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data; generic options are available. Both regions require detailed dossiers including clinical trial results, quality assurance, and pharmacovigilance plans for approval and ongoing safety monitoring. Due to its critical role in combatting resistant bacteria, strict prescribing and monitoring guidelines are enforced. For expert help with regulatory dossiers, compliance, and registration, visit PharmaTradz. We enable seamless market access aligned with European and US standards.

Meropenem Iv Infusion — third party manufacturing & bulk supply

Meropenem Iv Infusion 500 mg, 1 g, 2 g in vials is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Meropenem Iv Infusion is supplied as Powder for Reconstitution — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Meropenem Iv Infusion listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Meropenem Iv Infusion →

Back to Listing

Frequently Asked Questions

Meropenem is used to treat serious bacterial infections such as complicated intra-abdominal infections, meningitis, hospital-acquired pneumonia, and complicated skin and soft tissue infections. It is commonly administered in hospitals for infections caused by susceptible bacteria.

Meropenem is made from the active pharmaceutical ingredient meropenem trihydrate, a broad-spectrum carbapenem antibiotic that works by inhibiting bacterial cell wall synthesis and stopping the growth of bacteria.

Common trade names include Merrem and Merosan.

The originator brand Merrem was developed and marketed by AstraZeneca. Generic versions including Merosan and other brands are manufactured by various pharmaceutical companies globally.

The generic name is meropenem trihydrate.

Brand names include Merrem and Merosan.

Meropenem injections are manufactured in several countries including the United States, European countries, India, and Latin American regions in pharmaceutical facilities that follow regulatory standards such as US FDA, EMA, and other national authorities.